Global and Europe Blood system drugs Market - Analysis and Outlook to 2022
This report presents a comprehensive overview of the Blood system drugs market in Europe, which shares the history data information from 2012 to 2016, and forecast from 2017 to 2022.
This report provides a detailed analysis of the market, including its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Blood system drugs industry.
This report focuses Global and Europe market, including details as following:
Key Players
Blood system drugs Market, by Antianemic Agents
This report provides a detailed analysis of the market, including its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Blood system drugs industry.
This report focuses Global and Europe market, including details as following:
Key Players
- ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara
- Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free
- ASPEN OSS B.V. NL 5349 AB Oss
- BACHEM AMERICAS, INC. US 90505 Torrance
- BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona
- Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar
- CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village
- CHEMOSWED AB SE 212 15 Malm
- Cilag AG CH 8205 Schaffhausen
- DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch
- Erregierre S.p.A. IT 24060 San Paolo D'Argon
- ESTEVE QUIMICA S.A. ES 08024 Barcelona
- FSP GALENA PL 50-984 Wroclaw
- HEC PHARM GMBH DE 10963 Berlin
- Helm AG DE 20097 Hamburg
- HEMMO PHARMACEUTICALS PVT. LTD. IN 400 613 Mumbai
- Ind-Swift Laboratories Limited IN 160 101 Chandigarh
- Invitrogen Corporation US 92008 Carlsbad
- IPCA Laboratories Limited IN 400 067 Mumbai
- JUBILANT GENERICS LIMITED IN 571 302 Nanjangud
- KRKA d.d. SI 8501 Novo Mesto
- Laboratori Derivati Organici S.p.A. IT 20122 Milano
- LEO PHARMA A/S DK 2750 Ballerup
- LIFE TECHNOLOGIES CORPORATION US 92008 Carlsbad
- Lonza Braine S.A. BE 1420 Braine-L'Alleud
- MIDAS PHARMA GMBH DE 55218 Ingelheim am Rhein
- MP BIOMEDICALS NEW ZEALAND LIMITED NZ 0610 Auckland
- MSN LABORATORIES PRIVATE LIMITED IN 502 329 Rudraram Village
- MYLAN LABORATORIES LIMITED IN 502 325 Hyderabad
- North America
- United States
- Canada
- Latin America
- Mexico
- Brazil
- Argentina
- Others
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Russia
- Netherland
- Others
- Asia & Pacific
- China
- Japan
- India
- Korea
- Australia
- Southeast Asia
- Indonesia
- Thailand
- Philippines
- Vietnam
- Singapore
- Malaysia
- Others
- Africa & Middle East
- South Africa
- Egypt
- Turkey
- Saudi Arabia
- Iran
- Others
Blood system drugs Market, by Antianemic Agents
- Ferrous sulfate
- Ferrous succinate
- RHUEPO
- Iron-dextrin
- Vitamin B12
- Folic acid
- Mecobalamin
- Cobamamide
- Epogen/Procrit
- NeoRecormon
- Dynepo
- Eporatio/Biopoin
- Aranesp/NESP
- Mircera/CERA
- Binocrit
- Abseamed
- Epoetin Alfa Hexal
- Retacrit/Silapo
- Aspirin
- Dipyridamole
- Clopidogrel
- Prasugrel
- Ticagrelor
- Glycoprotein
- Aggrastat
- Cilostazol
- Ticlopidine
- Cangrelor
- Vorapaxar
- Atopaxar
- Sarpogrelate
- Thrombin
- Etamsylate
- Menadione Sodium Bisulfite
- Vitamin K1
- Aminomethylbenzoic Acid
- Desmopressin acetate
- Human Coagulation Factor
- Prothrombin Complex
- Artificial fibrinogen
- Aminomethylbenzoic Acid
- Tranexamic acid
- Aprotinin
- Aminocaproic Acid
- Carbazochrome
- Pituitrin
- heparin
- urokinase
- Warfarin
- Bishydroxycoumarin
- Streptokinase
- Silteplase
- Hydroxyethyl starch 40
- Dextran
- Polyglucose
- department of hematology
- Internal Medicine
- department of surgery
- Pharmacy
- Hospital
Global and Europe Blood system drugs Market - Analysis and Outlook to 2022
1 MARKET OUTLINE
1.1 Research Methodology
1.1.1 Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
1.1.2 Data Source
Secondary Sources
Primary Sources
1.1.3 Disclaimer
1.2 Regulatory Factors
1.3 End-User Analysis
1.4 Strategic Benchmarking
1.5 Industry Chain and Supply Chain
1.5.1 Blood system drugs Industry Chain Structure
1.5.1.1 R&D
1.5.1.2 Raw Materials (Components)
1.5.1.3 Manufacturing Plants
1.5.1.4 Regional Trading (Import Export and Local Sales)
1.5.1.5 Online Sales Channel
1.5.1.6 Offline Channel
1.5.1.7 End Users
1.5.2 Blood system drugs Manufacturing
1.5.2.1 Key Components
1.5.2.2 Assembly Manufacturing
1.5.3 Consumer Preference
1.5.4 Behavioral Habits
1.5.5 Marketing Environment
1.6 SWOT Analysis
1.7 Feasibility Analysis
1.8 Development Trend and Research Conclusion
1.8.1 Development Trend
1.8.2 Research Conclusion
2 GLOBAL BLOOD SYSTEM DRUGS PRODUCT OVERVIEW
2.1 Global Blood system drugs Market Sales Volume Revenue and Price 2012-2017
2.2 Blood system drugs, by Antianemic Agents 2012-2017
2.2.1 Global Blood system drugs Sales Market Share by Antianemic Agents 2012-2017
2.2.2 Global Blood system drugs Revenue Market Share by Antianemic Agents 2012-2017
2.2.3 Global Blood system drugs Price by Antianemic Agents 2012-2017
2.2.4 Ferrous sulfate
2.2.5 Ferrous succinate
2.2.6 RHUEPO
2.2.7 Iron-dextrin
2.2.8 Vitamin B12
2.2.9 Folic acid
2.2.10 Mecobalamin
2.2.11 Cobamamide
2.3 Blood system drugs, by Antiplatelet drug 2012-2017
2.3.1 Global Blood system drugs Sales Market Share by Antiplatelet drug 2012-2017
2.3.2 Global Blood system drugs Revenue Market Share by Antiplatelet drug 2012-2017
2.3.3 Global Blood system drugs Price by Antiplatelet drug 2012-2017
2.3.4 Aspirin
2.3.5 Dipyridamole
2.3.6 Clopidogrel
2.3.7 Prasugrel
2.3.8 Ticagrelor
2.3.9 Cangrelor
2.3.10 Vorapaxar
2.3.11 Atopaxar
2.3.12 Sarpogrelate
2.4 Blood system drugs, by Coagulant Drugs 2012-2017
2.4.1 Global Blood system drugs Sales Market Share by Coagulant Drugs 2012-2017
2.4.2 Global Blood system drugs Revenue Market Share by Coagulant Drugs 2012-2017
2.4.3 Global Blood system drugs Price by Coagulant Drugs 2012-2017
2.4.4 Thrombin
2.4.5 Etamsylate
2.4.6 Menadione Sodium Bisulfite
2.4.7 Vitamin K1
2.4.8 Aminomethylbenzoic Acid
2.4.9 Desmopressin acetate
2.4.10 Human Coagulation Factor
2.4.11 Prothrombin Complex
2.4.12 Artificial fibrinogen
2.4.13 Aminomethylbenzoic Acid
2.4.14 Tranexamic acid
2.4.15 Aprotinin
2.4.16 Aminocaproic Acid
2.4.17 Carbazochrome
2.4.18 Pituitrin
2.5 Blood system drugs, by Anticoagulant and thrombolytic 2012-2017
2.5.1 Global Blood system drugs Sales Market Share by Anticoagulant and thrombolytic 2012-2017
2.5.2 Global Blood system drugs Revenue Market Share by Anticoagulant and thrombolytic 2012-2017
2.5.3 Global Blood system drugs Price by Anticoagulant and thrombolytic 2012-2017
2.5.4 heparin
2.5.5 urokinase
2.5.6 Warfarin
2.5.7 Bishydroxycoumarin
2.5.8 Streptokinase
2.5.9 Silteplase
2.6 Blood system drugs, by blood volume expander 2012-2017
2.6.1 Global Blood system drugs Sales Market Share by blood volume expander 2012-2017
2.6.2 Global Blood system drugs Revenue Market Share by blood volume expander 2012-2017
2.6.3 Global Blood system drugs Price by blood volume expander 2012-2017
2.6.4 Hydroxyethyl starch
2.6.5 Dextran
2.6.6 Polyglucose
3 EUROPE BLOOD SYSTEM DRUGS PRODUCT OVERVIEW
3.1 Europe Blood system drugs Market Sales Volume Revenue and Price 2012-2017
3.2 Blood system drugs, by Antianemic Agents 2012-2017
3.2.1 Europe Blood system drugs Sales Market Share by Antianemic Agents 2012-2017
3.2.2 Europe Blood system drugs Revenue Market Share by Antianemic Agents 2012-2017
3.2.3 Europe Blood system drugs Price by Antianemic Agents 2012-2017
3.2.4 Ferrous sulfate
3.2.5 Ferrous succinate
3.2.6 RHUEPO
3.2.7 Iron-dextrin
3.2.8 Vitamin B12
3.2.9 Folic acid
3.2.10 Mecobalamin
3.2.11 Cobamamide
3.3 Blood system drugs, by Antiplatelet drug 2012-2017
3.3.1 Europe Blood system drugs Sales Market Share by Antiplatelet drug 2012-2017
3.3.2 Europe Blood system drugs Revenue Market Share by Antiplatelet drug 2012-2017
3.3.3 Europe Blood system drugs Price by Antiplatelet drug 2012-2017
3.3.4 Aspirin
3.3.5 Dipyridamole
3.3.6 Clopidogrel
3.3.7 Prasugrel
3.3.8 Ticagrelor
3.3.9 Cangrelor
3.3.10 Vorapaxar
3.3.11 Atopaxar
3.3.12 Sarpogrelate
3.4 Blood system drugs, by Coagulant Drugs 2012-2017
3.4.1 Europe Blood system drugs Sales Market Share by Coagulant Drugs 2012-2017
3.4.2 Europe Blood system drugs Revenue Market Share by Coagulant Drugs 2012-2017
3.4.3 Europe Blood system drugs Price by Coagulant Drugs 2012-2017
3.4.4 Thrombin
3.4.5 Etamsylate
3.4.6 Menadione Sodium Bisulfite
3.4.7 Vitamin K1
3.4.8 Aminomethylbenzoic Acid
3.4.9 Desmopressin acetate
3.4.10 Human Coagulation Factor
3.4.11 Prothrombin Complex
3.4.12 Artificial fibrinogen
3.4.13 Aminomethylbenzoic Acid
3.4.14 Tranexamic acid
3.4.15 Aprotinin
3.4.16 Aminocaproic Acid
3.4.17 Carbazochrome
3.4.18 Pituitrin
3.5 Blood system drugs, by Anticoagulant and thrombolytic 2012-2017
3.5.1 Europe Blood system drugs Sales Market Share by Anticoagulant and thrombolytic 2012-2017
3.5.2 Europe Blood system drugs Revenue Market Share by Anticoagulant and thrombolytic 2012-2017
3.5.3 Europe Blood system drugs Price by Anticoagulant and thrombolytic 2012-2017
3.5.4 heparin
3.5.5 urokinase
3.5.6 Warfarin
3.5.7 Bishydroxycoumarin
3.5.8 Streptokinase
3.5.9 Silteplase
3.6 Blood system drugs, by blood volume expander 2012-2017
3.6.1 Europe Blood system drugs Sales Market Share by blood volume expander 2012-2017
3.6.2 Europe Blood system drugs Revenue Market Share by blood volume expander 2012-2017
3.6.3 Europe Blood system drugs Price by blood volume expander 2012-2017
3.6.4 Hydroxyethyl starch
3.6.5 Dextran
3.6.6 Polyglucose
4 BLOOD SYSTEM DRUGS TOP COMPANIES PROFILE
4.1 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara
4.1.1 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Company Details and Competitors
4.1.2 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Key Blood system drugs Models and Performance
4.1.3 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Blood system drugs Business SWOT Analysis and Forecast
4.1.4 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
4.2 Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free
4.2.1 Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free Company Details and Competitors
4.2.2 Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free Key Blood system drugs Models and Performance
4.2.3 Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free Blood system drugs Business SWOT Analysis and Forecast
4.2.4 Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
4.3 ASPEN OSS B.V. NL 5349 AB Oss
4.3.1 ASPEN OSS B.V. NL 5349 AB Oss Company Details and Competitors
4.3.2 ASPEN OSS B.V. NL 5349 AB Oss Key Blood system drugs Models and Performance
4.3.3 ASPEN OSS B.V. NL 5349 AB Oss Blood system drugs Business SWOT Analysis and Forecast
4.3.4 ASPEN OSS B.V. NL 5349 AB Oss Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
4.4 BACHEM AMERICAS, INC. US 90505 Torrance
4.4.1 BACHEM AMERICAS, INC. US 90505 Torrance Company Details and Competitors
4.4.2 BACHEM AMERICAS, INC. US 90505 Torrance Key Blood system drugs Models and Performance
4.4.3 BACHEM AMERICAS, INC. US 90505 Torrance Blood system drugs Business SWOT Analysis and Forecast
4.4.4 BACHEM AMERICAS, INC. US 90505 Torrance Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
4.5 BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona
4.5.1 BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona Company Details and Competitors
4.5.2 BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona Key Blood system drugs Models and Performance
4.5.3 BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona Blood system drugs Business SWOT Analysis and Forecast
4.5.4 BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
4.6 Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar
4.6.1 Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar Company Details and Competitors
4.6.2 Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar Key Blood system drugs Models and Performance
4.6.3 Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar Blood system drugs Business SWOT Analysis and Forecast
4.6.4 Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
4.7 CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village
4.7.1 CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village Company Details and Competitors
4.7.2 CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village Key Blood system drugs Models and Performance
4.7.3 CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village Blood system drugs Business SWOT Analysis and Forecast
4.7.4 CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
4.8 CHEMOSWED AB SE 212 15 Malm
4.8.1 CHEMOSWED AB SE 212 15 Malm Company Details and Competitors
4.8.2 CHEMOSWED AB SE 212 15 Malm Key Blood system drugs Models and Performance
4.8.3 CHEMOSWED AB SE 212 15 Malm Blood system drugs Business SWOT Analysis and Forecast
4.8.4 CHEMOSWED AB SE 212 15 Malm Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
4.9 Cilag AG CH 8205 Schaffhausen
4.9.1 Cilag AG CH 8205 Schaffhausen Company Details and Competitors
4.9.2 Cilag AG CH 8205 Schaffhausen Key Blood system drugs Models and Performance
4.9.3 Cilag AG CH 8205 Schaffhausen Blood system drugs Business SWOT Analysis and Forecast
4.9.4 Cilag AG CH 8205 Schaffhausen Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
4.10 DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch
4.10.1 DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch Company Details and Competitors
4.10.2 DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch Key Blood system drugs Models and Performance
4.10.3 DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch Blood system drugs Business SWOT Analysis and Forecast
4.10.4 DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
4.11 Erregierre S.p.A. IT 24060 San Paolo D'Argon
4.12 ESTEVE QUIMICA S.A. ES 08024 Barcelona
4.13 FSP GALENA PL 50-984 Wroclaw
4.14 HEC PHARM GMBH DE 10963 Berlin
4.15 Helm AG DE 20097 Hamburg
4.16 HEMMO PHARMACEUTICALS PVT. LTD. IN 400 613 Mumbai
4.17 Ind-Swift Laboratories Limited IN 160 101 Chandigarh
4.18 Invitrogen Corporation US 92008 Carlsbad
4.19 IPCA Laboratories Limited IN 400 067 Mumbai
4.20 JUBILANT GENERICS LIMITED IN 571 302 Nanjangud
4.21 KRKA d.d. SI 8501 Novo Mesto
4.22 Laboratori Derivati Organici S.p.A. IT 20122 Milano
4.23 LEO PHARMA A/S DK 2750 Ballerup
4.24 LIFE TECHNOLOGIES CORPORATION US 92008 Carlsbad
4.25 Lonza Braine S.A. BE 1420 Braine-L'Alleud
4.26 MIDAS PHARMA GMBH DE 55218 Ingelheim am Rhein
4.27 MP BIOMEDICALS NEW ZEALAND LIMITED NZ 0610 Auckland
4.28 MSN LABORATORIES PRIVATE LIMITED IN 502 329 Rudraram Village
4.29 MYLAN LABORATORIES LIMITED IN 502 325 Hyderabad
5 BLOOD SYSTEM DRUGS BY REGIONS 2012-2017
5.1 Global Blood system drugs Sales Market Share by Regions 2012-2017
5.2 Global Blood system drugs Revenue Market Share by Regions 2012-2017
5.3 Global Blood system drugs Price by Regions 2012-2017
5.4 North America
5.4.1 United States
5.4.2 Canada
5.5 Latin America
5.5.1 Mexico
5.5.2 Brazil
5.5.3 Argentina
5.5.4 Others in Latin America
5.6 Europe
5.6.1 Germany
5.6.2 United Kingdom
5.6.3 France
5.6.4 Italy
5.6.5 Spain
5.6.6 Russia
5.6.7 Netherland
5.6.8 Others in Europe
5.7 Asia & Pacific
5.7.1 China
5.7.2 Japan
5.7.3 India
5.7.4 Korea
5.7.5 Australia
5.7.6 Southeast Asia
5.7.6.1 Indonesia
5.7.6.2 Thailand
5.7.6.3 Philippines
5.7.6.4 Vietnam
5.7.6.5 Singapore
5.7.6.6 Malaysia
5.7.6.7 Others in Southeast Asia
5.8 Africa & Middle East
5.8.1 South Africa
5.8.2 Egypt
5.8.3 Turkey
5.8.4 Saudi Arabia
5.8.5 Iran
5.8.6 Others in Africa & Middle East
6 GLOBALBLOOD SYSTEM DRUGS BY PLAYERS 2012-2017
6.1 Global Blood system drugs Sales Volume Market Share by Brands 2012-2017
6.2 Global Blood system drugs Revenue Share by Brands 2012-2017
6.3 Global Top Players Blood system drugs Key Product Model and Market Performance
6.4 Global Top Players Blood system drugs Key Target Consumers and Market Performance
7 EUROPEBLOOD SYSTEM DRUGS BY PLAYERS 2012-2017
7.1 Europe Blood system drugs Sales Volume Market Share by Brands 2012-2017
7.2 Europe Blood system drugs Revenue Share by Brands 2012-2017
7.3 Europe Top Players Blood system drugs Key Product Model and Market Performance
7.4 Europe Top Players Blood system drugs Key Target Consumers and Market Performance
8 GLOBAL BLOOD SYSTEM DRUGS BY CONSUMER 2012-2017
8.1 Global Blood system drugs Sales Market Share by Consumer 2012-2017
8.2 department of hematology
8.3 Internal Medicine
8.4 department of surgery
8.5 Pharmacy
8.6 Hospital
8.7 Consuming Habit and Preference
9 EUROPE BLOOD SYSTEM DRUGS BY CONSUMER 2012-2017
9.1 Europe Blood system drugs Sales Market Share by Consumer 2012-2017
9.2 department of hematology
9.3 Internal Medicine
9.4 department of surgery
9.5 Pharmacy
9.6 Hospital
9.7 Consuming Habit and Preference
10 GLOBAL BLOOD SYSTEM DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
10.1 Global Blood system drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
10.2 Global Blood system drugs Sales () Forecast by Regions (2017-2022)
10.3 Global Blood system drugs Sales () Forecast by Application (2017-2022)
10.4 Global Blood system drugs Sales () Forecast by Antianemic Agents (2017-2022)
10.5 Global Blood system drugs Sales () Forecast by Antiplatelet drug (2017-2022)
10.6 Global Blood system drugs Sales () Forecast by Coagulant Drugs (2017-2022)
10.7 Global Blood system drugs Sales () Forecast by Anticoagulant and thrombolytic (2017-2022)
10.8 Global Blood system drugs Sales () Forecast by blood volume expander (2017-2022)
11 EUROPE BLOOD SYSTEM DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
11.1 Europe Blood system drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
11.2 Europe Blood system drugs Sales () Forecast by Regions (2017-2022)
11.3 Europe Blood system drugs Sales () Forecast by Application (2017-2022)
11.4 Europe Blood system drugs Sales () Forecast by Antianemic Agents (2017-2022)
11.5 Europe Blood system drugs Sales () Forecast by Antiplatelet drug (2017-2022)
11.6 Europe Blood system drugs Sales () Forecast by Coagulant Drugs (2017-2022)
11.7 Europe Blood system drugs Sales () Forecast by Anticoagulant and thrombolytic (2017-2022)
11.8 Europe Blood system drugs Sales () Forecast by blood volume expander (2017-2022)
1 MARKET OUTLINE
1.1 Research Methodology
1.1.1 Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
1.1.2 Data Source
Secondary Sources
Primary Sources
1.1.3 Disclaimer
1.2 Regulatory Factors
1.3 End-User Analysis
1.4 Strategic Benchmarking
1.5 Industry Chain and Supply Chain
1.5.1 Blood system drugs Industry Chain Structure
1.5.1.1 R&D
1.5.1.2 Raw Materials (Components)
1.5.1.3 Manufacturing Plants
1.5.1.4 Regional Trading (Import Export and Local Sales)
1.5.1.5 Online Sales Channel
1.5.1.6 Offline Channel
1.5.1.7 End Users
1.5.2 Blood system drugs Manufacturing
1.5.2.1 Key Components
1.5.2.2 Assembly Manufacturing
1.5.3 Consumer Preference
1.5.4 Behavioral Habits
1.5.5 Marketing Environment
1.6 SWOT Analysis
1.7 Feasibility Analysis
1.8 Development Trend and Research Conclusion
1.8.1 Development Trend
1.8.2 Research Conclusion
2 GLOBAL BLOOD SYSTEM DRUGS PRODUCT OVERVIEW
2.1 Global Blood system drugs Market Sales Volume Revenue and Price 2012-2017
2.2 Blood system drugs, by Antianemic Agents 2012-2017
2.2.1 Global Blood system drugs Sales Market Share by Antianemic Agents 2012-2017
2.2.2 Global Blood system drugs Revenue Market Share by Antianemic Agents 2012-2017
2.2.3 Global Blood system drugs Price by Antianemic Agents 2012-2017
2.2.4 Ferrous sulfate
2.2.5 Ferrous succinate
2.2.6 RHUEPO
2.2.7 Iron-dextrin
2.2.8 Vitamin B12
2.2.9 Folic acid
2.2.10 Mecobalamin
2.2.11 Cobamamide
2.3 Blood system drugs, by Antiplatelet drug 2012-2017
2.3.1 Global Blood system drugs Sales Market Share by Antiplatelet drug 2012-2017
2.3.2 Global Blood system drugs Revenue Market Share by Antiplatelet drug 2012-2017
2.3.3 Global Blood system drugs Price by Antiplatelet drug 2012-2017
2.3.4 Aspirin
2.3.5 Dipyridamole
2.3.6 Clopidogrel
2.3.7 Prasugrel
2.3.8 Ticagrelor
2.3.9 Cangrelor
2.3.10 Vorapaxar
2.3.11 Atopaxar
2.3.12 Sarpogrelate
2.4 Blood system drugs, by Coagulant Drugs 2012-2017
2.4.1 Global Blood system drugs Sales Market Share by Coagulant Drugs 2012-2017
2.4.2 Global Blood system drugs Revenue Market Share by Coagulant Drugs 2012-2017
2.4.3 Global Blood system drugs Price by Coagulant Drugs 2012-2017
2.4.4 Thrombin
2.4.5 Etamsylate
2.4.6 Menadione Sodium Bisulfite
2.4.7 Vitamin K1
2.4.8 Aminomethylbenzoic Acid
2.4.9 Desmopressin acetate
2.4.10 Human Coagulation Factor
2.4.11 Prothrombin Complex
2.4.12 Artificial fibrinogen
2.4.13 Aminomethylbenzoic Acid
2.4.14 Tranexamic acid
2.4.15 Aprotinin
2.4.16 Aminocaproic Acid
2.4.17 Carbazochrome
2.4.18 Pituitrin
2.5 Blood system drugs, by Anticoagulant and thrombolytic 2012-2017
2.5.1 Global Blood system drugs Sales Market Share by Anticoagulant and thrombolytic 2012-2017
2.5.2 Global Blood system drugs Revenue Market Share by Anticoagulant and thrombolytic 2012-2017
2.5.3 Global Blood system drugs Price by Anticoagulant and thrombolytic 2012-2017
2.5.4 heparin
2.5.5 urokinase
2.5.6 Warfarin
2.5.7 Bishydroxycoumarin
2.5.8 Streptokinase
2.5.9 Silteplase
2.6 Blood system drugs, by blood volume expander 2012-2017
2.6.1 Global Blood system drugs Sales Market Share by blood volume expander 2012-2017
2.6.2 Global Blood system drugs Revenue Market Share by blood volume expander 2012-2017
2.6.3 Global Blood system drugs Price by blood volume expander 2012-2017
2.6.4 Hydroxyethyl starch
2.6.5 Dextran
2.6.6 Polyglucose
3 EUROPE BLOOD SYSTEM DRUGS PRODUCT OVERVIEW
3.1 Europe Blood system drugs Market Sales Volume Revenue and Price 2012-2017
3.2 Blood system drugs, by Antianemic Agents 2012-2017
3.2.1 Europe Blood system drugs Sales Market Share by Antianemic Agents 2012-2017
3.2.2 Europe Blood system drugs Revenue Market Share by Antianemic Agents 2012-2017
3.2.3 Europe Blood system drugs Price by Antianemic Agents 2012-2017
3.2.4 Ferrous sulfate
3.2.5 Ferrous succinate
3.2.6 RHUEPO
3.2.7 Iron-dextrin
3.2.8 Vitamin B12
3.2.9 Folic acid
3.2.10 Mecobalamin
3.2.11 Cobamamide
3.3 Blood system drugs, by Antiplatelet drug 2012-2017
3.3.1 Europe Blood system drugs Sales Market Share by Antiplatelet drug 2012-2017
3.3.2 Europe Blood system drugs Revenue Market Share by Antiplatelet drug 2012-2017
3.3.3 Europe Blood system drugs Price by Antiplatelet drug 2012-2017
3.3.4 Aspirin
3.3.5 Dipyridamole
3.3.6 Clopidogrel
3.3.7 Prasugrel
3.3.8 Ticagrelor
3.3.9 Cangrelor
3.3.10 Vorapaxar
3.3.11 Atopaxar
3.3.12 Sarpogrelate
3.4 Blood system drugs, by Coagulant Drugs 2012-2017
3.4.1 Europe Blood system drugs Sales Market Share by Coagulant Drugs 2012-2017
3.4.2 Europe Blood system drugs Revenue Market Share by Coagulant Drugs 2012-2017
3.4.3 Europe Blood system drugs Price by Coagulant Drugs 2012-2017
3.4.4 Thrombin
3.4.5 Etamsylate
3.4.6 Menadione Sodium Bisulfite
3.4.7 Vitamin K1
3.4.8 Aminomethylbenzoic Acid
3.4.9 Desmopressin acetate
3.4.10 Human Coagulation Factor
3.4.11 Prothrombin Complex
3.4.12 Artificial fibrinogen
3.4.13 Aminomethylbenzoic Acid
3.4.14 Tranexamic acid
3.4.15 Aprotinin
3.4.16 Aminocaproic Acid
3.4.17 Carbazochrome
3.4.18 Pituitrin
3.5 Blood system drugs, by Anticoagulant and thrombolytic 2012-2017
3.5.1 Europe Blood system drugs Sales Market Share by Anticoagulant and thrombolytic 2012-2017
3.5.2 Europe Blood system drugs Revenue Market Share by Anticoagulant and thrombolytic 2012-2017
3.5.3 Europe Blood system drugs Price by Anticoagulant and thrombolytic 2012-2017
3.5.4 heparin
3.5.5 urokinase
3.5.6 Warfarin
3.5.7 Bishydroxycoumarin
3.5.8 Streptokinase
3.5.9 Silteplase
3.6 Blood system drugs, by blood volume expander 2012-2017
3.6.1 Europe Blood system drugs Sales Market Share by blood volume expander 2012-2017
3.6.2 Europe Blood system drugs Revenue Market Share by blood volume expander 2012-2017
3.6.3 Europe Blood system drugs Price by blood volume expander 2012-2017
3.6.4 Hydroxyethyl starch
3.6.5 Dextran
3.6.6 Polyglucose
4 BLOOD SYSTEM DRUGS TOP COMPANIES PROFILE
4.1 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara
4.1.1 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Company Details and Competitors
4.1.2 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Key Blood system drugs Models and Performance
4.1.3 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Blood system drugs Business SWOT Analysis and Forecast
4.1.4 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
4.2 Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free
4.2.1 Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free Company Details and Competitors
4.2.2 Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free Key Blood system drugs Models and Performance
4.2.3 Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free Blood system drugs Business SWOT Analysis and Forecast
4.2.4 Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
4.3 ASPEN OSS B.V. NL 5349 AB Oss
4.3.1 ASPEN OSS B.V. NL 5349 AB Oss Company Details and Competitors
4.3.2 ASPEN OSS B.V. NL 5349 AB Oss Key Blood system drugs Models and Performance
4.3.3 ASPEN OSS B.V. NL 5349 AB Oss Blood system drugs Business SWOT Analysis and Forecast
4.3.4 ASPEN OSS B.V. NL 5349 AB Oss Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
4.4 BACHEM AMERICAS, INC. US 90505 Torrance
4.4.1 BACHEM AMERICAS, INC. US 90505 Torrance Company Details and Competitors
4.4.2 BACHEM AMERICAS, INC. US 90505 Torrance Key Blood system drugs Models and Performance
4.4.3 BACHEM AMERICAS, INC. US 90505 Torrance Blood system drugs Business SWOT Analysis and Forecast
4.4.4 BACHEM AMERICAS, INC. US 90505 Torrance Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
4.5 BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona
4.5.1 BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona Company Details and Competitors
4.5.2 BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona Key Blood system drugs Models and Performance
4.5.3 BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona Blood system drugs Business SWOT Analysis and Forecast
4.5.4 BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
4.6 Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar
4.6.1 Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar Company Details and Competitors
4.6.2 Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar Key Blood system drugs Models and Performance
4.6.3 Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar Blood system drugs Business SWOT Analysis and Forecast
4.6.4 Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
4.7 CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village
4.7.1 CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village Company Details and Competitors
4.7.2 CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village Key Blood system drugs Models and Performance
4.7.3 CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village Blood system drugs Business SWOT Analysis and Forecast
4.7.4 CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
4.8 CHEMOSWED AB SE 212 15 Malm
4.8.1 CHEMOSWED AB SE 212 15 Malm Company Details and Competitors
4.8.2 CHEMOSWED AB SE 212 15 Malm Key Blood system drugs Models and Performance
4.8.3 CHEMOSWED AB SE 212 15 Malm Blood system drugs Business SWOT Analysis and Forecast
4.8.4 CHEMOSWED AB SE 212 15 Malm Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
4.9 Cilag AG CH 8205 Schaffhausen
4.9.1 Cilag AG CH 8205 Schaffhausen Company Details and Competitors
4.9.2 Cilag AG CH 8205 Schaffhausen Key Blood system drugs Models and Performance
4.9.3 Cilag AG CH 8205 Schaffhausen Blood system drugs Business SWOT Analysis and Forecast
4.9.4 Cilag AG CH 8205 Schaffhausen Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
4.10 DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch
4.10.1 DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch Company Details and Competitors
4.10.2 DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch Key Blood system drugs Models and Performance
4.10.3 DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch Blood system drugs Business SWOT Analysis and Forecast
4.10.4 DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
4.11 Erregierre S.p.A. IT 24060 San Paolo D'Argon
4.12 ESTEVE QUIMICA S.A. ES 08024 Barcelona
4.13 FSP GALENA PL 50-984 Wroclaw
4.14 HEC PHARM GMBH DE 10963 Berlin
4.15 Helm AG DE 20097 Hamburg
4.16 HEMMO PHARMACEUTICALS PVT. LTD. IN 400 613 Mumbai
4.17 Ind-Swift Laboratories Limited IN 160 101 Chandigarh
4.18 Invitrogen Corporation US 92008 Carlsbad
4.19 IPCA Laboratories Limited IN 400 067 Mumbai
4.20 JUBILANT GENERICS LIMITED IN 571 302 Nanjangud
4.21 KRKA d.d. SI 8501 Novo Mesto
4.22 Laboratori Derivati Organici S.p.A. IT 20122 Milano
4.23 LEO PHARMA A/S DK 2750 Ballerup
4.24 LIFE TECHNOLOGIES CORPORATION US 92008 Carlsbad
4.25 Lonza Braine S.A. BE 1420 Braine-L'Alleud
4.26 MIDAS PHARMA GMBH DE 55218 Ingelheim am Rhein
4.27 MP BIOMEDICALS NEW ZEALAND LIMITED NZ 0610 Auckland
4.28 MSN LABORATORIES PRIVATE LIMITED IN 502 329 Rudraram Village
4.29 MYLAN LABORATORIES LIMITED IN 502 325 Hyderabad
5 BLOOD SYSTEM DRUGS BY REGIONS 2012-2017
5.1 Global Blood system drugs Sales Market Share by Regions 2012-2017
5.2 Global Blood system drugs Revenue Market Share by Regions 2012-2017
5.3 Global Blood system drugs Price by Regions 2012-2017
5.4 North America
5.4.1 United States
5.4.2 Canada
5.5 Latin America
5.5.1 Mexico
5.5.2 Brazil
5.5.3 Argentina
5.5.4 Others in Latin America
5.6 Europe
5.6.1 Germany
5.6.2 United Kingdom
5.6.3 France
5.6.4 Italy
5.6.5 Spain
5.6.6 Russia
5.6.7 Netherland
5.6.8 Others in Europe
5.7 Asia & Pacific
5.7.1 China
5.7.2 Japan
5.7.3 India
5.7.4 Korea
5.7.5 Australia
5.7.6 Southeast Asia
5.7.6.1 Indonesia
5.7.6.2 Thailand
5.7.6.3 Philippines
5.7.6.4 Vietnam
5.7.6.5 Singapore
5.7.6.6 Malaysia
5.7.6.7 Others in Southeast Asia
5.8 Africa & Middle East
5.8.1 South Africa
5.8.2 Egypt
5.8.3 Turkey
5.8.4 Saudi Arabia
5.8.5 Iran
5.8.6 Others in Africa & Middle East
6 GLOBALBLOOD SYSTEM DRUGS BY PLAYERS 2012-2017
6.1 Global Blood system drugs Sales Volume Market Share by Brands 2012-2017
6.2 Global Blood system drugs Revenue Share by Brands 2012-2017
6.3 Global Top Players Blood system drugs Key Product Model and Market Performance
6.4 Global Top Players Blood system drugs Key Target Consumers and Market Performance
7 EUROPEBLOOD SYSTEM DRUGS BY PLAYERS 2012-2017
7.1 Europe Blood system drugs Sales Volume Market Share by Brands 2012-2017
7.2 Europe Blood system drugs Revenue Share by Brands 2012-2017
7.3 Europe Top Players Blood system drugs Key Product Model and Market Performance
7.4 Europe Top Players Blood system drugs Key Target Consumers and Market Performance
8 GLOBAL BLOOD SYSTEM DRUGS BY CONSUMER 2012-2017
8.1 Global Blood system drugs Sales Market Share by Consumer 2012-2017
8.2 department of hematology
8.3 Internal Medicine
8.4 department of surgery
8.5 Pharmacy
8.6 Hospital
8.7 Consuming Habit and Preference
9 EUROPE BLOOD SYSTEM DRUGS BY CONSUMER 2012-2017
9.1 Europe Blood system drugs Sales Market Share by Consumer 2012-2017
9.2 department of hematology
9.3 Internal Medicine
9.4 department of surgery
9.5 Pharmacy
9.6 Hospital
9.7 Consuming Habit and Preference
10 GLOBAL BLOOD SYSTEM DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
10.1 Global Blood system drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
10.2 Global Blood system drugs Sales () Forecast by Regions (2017-2022)
10.3 Global Blood system drugs Sales () Forecast by Application (2017-2022)
10.4 Global Blood system drugs Sales () Forecast by Antianemic Agents (2017-2022)
10.5 Global Blood system drugs Sales () Forecast by Antiplatelet drug (2017-2022)
10.6 Global Blood system drugs Sales () Forecast by Coagulant Drugs (2017-2022)
10.7 Global Blood system drugs Sales () Forecast by Anticoagulant and thrombolytic (2017-2022)
10.8 Global Blood system drugs Sales () Forecast by blood volume expander (2017-2022)
11 EUROPE BLOOD SYSTEM DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
11.1 Europe Blood system drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
11.2 Europe Blood system drugs Sales () Forecast by Regions (2017-2022)
11.3 Europe Blood system drugs Sales () Forecast by Application (2017-2022)
11.4 Europe Blood system drugs Sales () Forecast by Antianemic Agents (2017-2022)
11.5 Europe Blood system drugs Sales () Forecast by Antiplatelet drug (2017-2022)
11.6 Europe Blood system drugs Sales () Forecast by Coagulant Drugs (2017-2022)
11.7 Europe Blood system drugs Sales () Forecast by Anticoagulant and thrombolytic (2017-2022)
11.8 Europe Blood system drugs Sales () Forecast by blood volume expander (2017-2022)
LIST OF TABLES AND FIGURES
Table Global Blood system drugs Sales Volume (), Revenue (Million USD) and Price () (2012-2017)
Figure Global Blood system drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Global Blood system drugs Sales Volume () and Growth Rate (2012-2017)
Table Global Blood system drugs Sales () by Antianemic Agents (2012-2017)
Table Global Blood system drugs Sales Market Share by Antianemic Agents (2012-2017)
Figure Global Blood system drugs Sales Market Share by Antianemic Agents in 2016
Table Global Blood system drugs Revenue (Million USD) by Antianemic Agents (2012-2017)
Table Global Blood system drugs Revenue Market Share by Antianemic Agents (2012-2017)
Figure Global Blood system drugs Revenue Market Share by Antianemic Agents in 2016
Table Global Blood system drugs Price () by Antianemic Agents (2012-2017)
Table Top Players of Ferrous sulfate Blood system drugs Products List
Figure Global Ferrous sulfate Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Ferrous succinate Blood system drugs Products List
Figure Global Ferrous succinate Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of RHUEPO Blood system drugs Products List
Figure Global RHUEPO Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Iron-dextrin Blood system drugs Products List
Figure Global Iron-dextrin Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Vitamin B12 Blood system drugs Products List
Figure Global Vitamin B12 Blood system drugs Sales () and Growth Rate (2012-2017)
Table Global Blood system drugs Sales () by Antiplatelet drug (2012-2017)
Table Global Blood system drugs Sales Market Share by Antiplatelet drug (2012-2017)
Figure Global Blood system drugs Sales Market Share by Antiplatelet drug in 2016
Table Global Blood system drugs Revenue (Million USD) by Antiplatelet drug (2012-2017)
Table Global Blood system drugs Revenue Market Share by Antiplatelet drug (2012-2017)
Figure Global Blood system drugs Revenue Market Share by Antiplatelet drug in 2016
Table Global Blood system drugs Price () by Antiplatelet drug (2012-2017)
Table Top Players of Aspirin Blood system drugs Products List
Figure Global Aspirin Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Dipyridamole Blood system drugs Products List
Figure Global Dipyridamole Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Clopidogrel Blood system drugs Products List
Figure Global Clopidogrel Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Prasugrel Blood system drugs Products List
Figure Global Prasugrel Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Ticagrelor Blood system drugs Products List
Figure Global Ticagrelor Blood system drugs Sales () and Growth Rate (2012-2017)
Table Global Blood system drugs Sales () by Coagulant Drugs (2012-2017)
Table Global Blood system drugs Sales Market Share by Coagulant Drugs (2012-2017)
Figure Global Blood system drugs Sales Market Share by Coagulant Drugs in 2016
Table Global Blood system drugs Revenue (Million USD) by Coagulant Drugs (2012-2017)
Table Global Blood system drugs Revenue Market Share by Coagulant Drugs (2012-2017)
Figure Global Blood system drugs Revenue Market Share by Coagulant Drugs in 2016
Table Global Blood system drugs Price () by Coagulant Drugs (2012-2017)
Table Top Players of Thrombin Blood system drugs Products List
Figure Global Thrombin Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Etamsylate Blood system drugs Products List
Figure Global Etamsylate Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Menadione Sodium Bisulfite Blood system drugs Products List
Figure Global Menadione Sodium Bisulfite Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Vitamin K1 Blood system drugs Products List
Figure Global Vitamin K1 Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Aminomethylbenzoic Acid Blood system drugs Products List
Figure Global Aminomethylbenzoic Acid Blood system drugs Sales () and Growth Rate (2012-2017)
Table Global Blood system drugs Sales () by Anticoagulant and thrombolytic (2012-2017)
Table Global Blood system drugs Sales Market Share by Anticoagulant and thrombolytic (2012-2017)
Figure Global Blood system drugs Sales Market Share by Anticoagulant and thrombolytic in 2016
Table Global Blood system drugs Revenue (Million USD) by Anticoagulant and thrombolytic (2012-2017)
Table Global Blood system drugs Revenue Market Share by Anticoagulant and thrombolytic (2012-2017)
Figure Global Blood system drugs Revenue Market Share by Anticoagulant and thrombolytic in 2016
Table Global Blood system drugs Price () by Anticoagulant and thrombolytic (2012-2017)
Table Top Players of heparin Blood system drugs Products List
Figure Global heparin Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of urokinase Blood system drugs Products List
Figure Global urokinase Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Warfarin Blood system drugs Products List
Figure Global Warfarin Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Bishydroxycoumarin Blood system drugs Products List
Figure Global Bishydroxycoumarin Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Streptokinase Blood system drugs Products List
Figure Global Streptokinase Blood system drugs Sales () and Growth Rate (2012-2017)
Table Global Blood system drugs Sales () by blood volume expander (2012-2017)
Table Global Blood system drugs Sales Market Share by blood volume expander (2012-2017)
Figure Global Blood system drugs Sales Market Share by blood volume expander in 2016
Table Global Blood system drugs Revenue (Million USD) by blood volume expander (2012-2017)
Table Global Blood system drugs Revenue Market Share by blood volume expander (2012-2017)
Figure Global Blood system drugs Revenue Market Share by blood volume expander in 2016
Table Global Blood system drugs Price () by blood volume expander (2012-2017)
Table Top Players of Hydroxyethyl starch 40 Blood system drugs Products List
Figure Global Hydroxyethyl starch 40 Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Dextran Blood system drugs Products List
Figure Global Dextran Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Polyglucose Blood system drugs Products List
Figure Global Polyglucose Blood system drugs Sales () and Growth Rate (2012-2017)
Table Europe Blood system drugs Sales Volume (), Revenue (Million USD) and Price () (2012-2017)
Figure Europe Blood system drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Blood system drugs Sales Volume () and Growth Rate (2012-2017)
Table Europe Blood system drugs Sales () by Antianemic Agents (2012-2017)
Table Europe Blood system drugs Sales Market Share by Antianemic Agents (2012-2017)
Figure Europe Blood system drugs Sales Market Share by Antianemic Agents in 2016
Table Europe Blood system drugs Revenue (Million USD) by Antianemic Agents (2012-2017)
Table Europe Blood system drugs Revenue Market Share by Antianemic Agents (2012-2017)
Figure Europe Blood system drugs Revenue Market Share by Antianemic Agents in 2016
Table Europe Blood system drugs Price () by Antianemic Agents (2012-2017)
Table Top Players of Ferrous sulfate Blood system drugs Products List
Figure Europe Ferrous sulfate Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Ferrous succinate Blood system drugs Products List
Figure Europe Ferrous succinate Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of RHUEPO Blood system drugs Products List
Figure Europe RHUEPO Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Iron-dextrin Blood system drugs Products List
Figure Europe Iron-dextrin Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Vitamin B12 Blood system drugs Products List
Figure Europe Vitamin B12 Blood system drugs Sales () and Growth Rate (2012-2017)
Table Europe Blood system drugs Sales () by Antiplatelet drug (2012-2017)
Table Europe Blood system drugs Sales Market Share by Antiplatelet drug (2012-2017)
Figure Europe Blood system drugs Sales Market Share by Antiplatelet drug in 2016
Table Europe Blood system drugs Revenue (Million USD) by Antiplatelet drug (2012-2017)
Table Europe Blood system drugs Revenue Market Share by Antiplatelet drug (2012-2017)
Figure Europe Blood system drugs Revenue Market Share by Antiplatelet drug in 2016
Table Europe Blood system drugs Price () by Antiplatelet drug (2012-2017)
Table Top Players of Aspirin Blood system drugs Products List
Figure Europe Aspirin Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Dipyridamole Blood system drugs Products List
Figure Europe Dipyridamole Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Clopidogrel Blood system drugs Products List
Figure Europe Clopidogrel Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Prasugrel Blood system drugs Products List
Figure Europe Prasugrel Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Ticagrelor Blood system drugs Products List
Figure Europe Ticagrelor Blood system drugs Sales () and Growth Rate (2012-2017)
Table Europe Blood system drugs Sales () by Coagulant Drugs (2012-2017)
Table Europe Blood system drugs Sales Market Share by Coagulant Drugs (2012-2017)
Figure Europe Blood system drugs Sales Market Share by Coagulant Drugs in 2016
Table Europe Blood system drugs Revenue (Million USD) by Coagulant Drugs (2012-2017)
Table Europe Blood system drugs Revenue Market Share by Coagulant Drugs (2012-2017)
Figure Europe Blood system drugs Revenue Market Share by Coagulant Drugs in 2016
Table Europe Blood system drugs Price () by Coagulant Drugs (2012-2017)
Table Top Players of Thrombin Blood system drugs Products List
Figure Europe Thrombin Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Etamsylate Blood system drugs Products List
Figure Europe Etamsylate Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Menadione Sodium Bisulfite Blood system drugs Products List
Figure Europe Menadione Sodium Bisulfite Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Vitamin K1 Blood system drugs Products List
Figure Europe Vitamin K1 Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Aminomethylbenzoic Acid Blood system drugs Products List
Figure Europe Aminomethylbenzoic Acid Blood system drugs Sales () and Growth Rate (2012-2017)
Table Europe Blood system drugs Sales () by Anticoagulant and thrombolytic (2012-2017)
Table Europe Blood system drugs Sales Market Share by Anticoagulant and thrombolytic (2012-2017)
Figure Europe Blood system drugs Sales Market Share by Anticoagulant and thrombolytic in 2016
Table Europe Blood system drugs Revenue (Million USD) by Anticoagulant and thrombolytic (2012-2017)
Table Europe Blood system drugs Revenue Market Share by Anticoagulant and thrombolytic (2012-2017)
Figure Europe Blood system drugs Revenue Market Share by Anticoagulant and thrombolytic in 2016
Table Europe Blood system drugs Price () by Anticoagulant and thrombolytic (2012-2017)
Table Top Players of heparin Blood system drugs Products List
Figure Europe heparin Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of urokinase Blood system drugs Products List
Figure Europe urokinase Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Warfarin Blood system drugs Products List
Figure Europe Warfarin Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Bishydroxycoumarin Blood system drugs Products List
Figure Europe Bishydroxycoumarin Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Streptokinase Blood system drugs Products List
Figure Europe Streptokinase Blood system drugs Sales () and Growth Rate (2012-2017)
Table Europe Blood system drugs Sales () by blood volume expander (2012-2017)
Table Europe Blood system drugs Sales Market Share by blood volume expander (2012-2017)
Figure Europe Blood system drugs Sales Market Share by blood volume expander in 2016
Table Europe Blood system drugs Revenue (Million USD) by blood volume expander (2012-2017)
Table Europe Blood system drugs Revenue Market Share by blood volume expander (2012-2017)
Figure Europe Blood system drugs Revenue Market Share by blood volume expander in 2016
Table Europe Blood system drugs Price () by blood volume expander (2012-2017)
Table Top Players of Hydroxyethyl starch 40 Blood system drugs Products List
Figure Europe Hydroxyethyl starch 40 Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Dextran Blood system drugs Products List
Figure Europe Dextran Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Polyglucose Blood system drugs Products List
Figure Europe Polyglucose Blood system drugs Sales () and Growth Rate (2012-2017)
Table ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Company Details and Competitors
Table ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Key Blood system drugs Models and Performance
Table ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Blood system drugs Business SWOT Analysis and Forecast
Table ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Blood system drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Blood system drugs Sales Market Share (%) in Global (2012-2017)
Figure ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Blood system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Blood system drugs Revenue Market Share (%) in Global (2012-2017)
Table Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free Company Details and Competitors
Table Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free Key Blood system drugs Models and Performance
Table Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free Blood system drugs Business SWOT Analysis and Forecast
Table Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free Blood system drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free Blood system drugs Sales Market Share (%) in Global (2012-2017)
Figure Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free Blood system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free Blood system drugs Revenue Market Share (%) in Global (2012-2017)
Table ASPEN OSS B.V. NL 5349 AB Oss Company Details and Competitors
Table ASPEN OSS B.V. NL 5349 AB Oss Key Blood system drugs Models and Performance
Table ASPEN OSS B.V. NL 5349 AB Oss Blood system drugs Business SWOT Analysis and Forecast
Table ASPEN OSS B.V. NL 5349 AB Oss Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure ASPEN OSS B.V. NL 5349 AB Oss Blood system drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure ASPEN OSS B.V. NL 5349 AB Oss Blood system drugs Sales Market Share (%) in Global (2012-2017)
Figure ASPEN OSS B.V. NL 5349 AB Oss Blood system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure ASPEN OSS B.V. NL 5349 AB Oss Blood system drugs Revenue Market Share (%) in Global (2012-2017)
Table BACHEM AMERICAS, INC. US 90505 Torrance Company Details and Competitors
Table BACHEM AMERICAS, INC. US 90505 Torrance Key Blood system drugs Models and Performance
Table BACHEM AMERICAS, INC. US 90505 Torrance Blood system drugs Business SWOT Analysis and Forecast
Table BACHEM AMERICAS, INC. US 90505 Torrance Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure BACHEM AMERICAS, INC. US 90505 Torrance Blood system drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure BACHEM AMERICAS, INC. US 90505 Torrance Blood system drugs Sales Market Share (%) in Global (2012-2017)
Figure BACHEM AMERICAS, INC. US 90505 Torrance Blood system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure BACHEM AMERICAS, INC. US 90505 Torrance Blood system drugs Revenue Market Share (%) in Global (2012-2017)
Table BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona Company Details and Competitors
Table BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona Key Blood system drugs Models and Performance
Table BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona Blood system drugs Business SWOT Analysis and Forecast
Table BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona Blood system drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona Blood system drugs Sales Market Share (%) in Global (2012-2017)
Figure BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona Blood system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona Blood system drugs Revenue Market Share (%) in Global (2012-2017)
Table Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar Company Details and Competitors
Table Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar Key Blood system drugs Models and Performance
Table Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar Blood system drugs Business SWOT Analysis and Forecast
Table Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar Blood system drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar Blood system drugs Sales Market Share (%) in Global (2012-2017)
Figure Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar Blood system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar Blood system drugs Revenue Market Share (%) in Global (2012-2017)
Table CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village Company Details and Competitors
Table CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village Key Blood system drugs Models and Performance
Table CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village Blood system drugs Business SWOT Analysis and Forecast
Table CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village Blood system drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village Blood system drugs Sales Market Share (%) in Global (2012-2017)
Figure CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village Blood system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village Blood system drugs Revenue Market Share (%) in Global (2012-2017)
Table CHEMOSWED AB SE 212 15 Malm Company Details and Competitors
Table CHEMOSWED AB SE 212 15 Malm Key Blood system drugs Models and Performance
Table CHEMOSWED AB SE 212 15 Malm Blood system drugs Business SWOT Analysis and Forecast
Table CHEMOSWED AB SE 212 15 Malm Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure CHEMOSWED AB SE 212 15 Malm Blood system drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure CHEMOSWED AB SE 212 15 Malm Blood system drugs Sales Market Share (%) in Global (2012-2017)
Figure CHEMOSWED AB SE 212 15 Malm Blood system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure CHEMOSWED AB SE 212 15 Malm Blood system drugs Revenue Market Share (%) in Global (2012-2017)
Table Cilag AG CH 8205 Schaffhausen Company Details and Competitors
Table Cilag AG CH 8205 Schaffhausen Key Blood system drugs Models and Performance
Table Cilag AG CH 8205 Schaffhausen Blood system drugs Business SWOT Analysis and Forecast
Table Cilag AG CH 8205 Schaffhausen Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure Cilag AG CH 8205 Schaffhausen Blood system drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure Cilag AG CH 8205 Schaffhausen Blood system drugs Sales Market Share (%) in Global (2012-2017)
Figure Cilag AG CH 8205 Schaffhausen Blood system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Cilag AG CH 8205 Schaffhausen Blood system drugs Revenue Market Share (%) in Global (2012-2017)
Table DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch Company Details and Competitors
Table DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch Key Blood system drugs Models and Performance
Table DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch Blood system drugs Business SWOT Analysis and Forecast
Table DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch Blood system drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch Blood system drugs Sales Market Share (%) in Global (2012-2017)
Figure DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch Blood system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch Blood system drugs Revenue Market Share (%) in Global (2012-2017)
Table Erregierre S.p.A. IT 24060 San Paolo D'Argon Company Details and Competitors
Table ESTEVE QUIMICA S.A. ES 08024 Barcelona Company Details and Competitors
Table FSP GALENA PL 50-984 Wroclaw Company Details and Competitors
Table HEC PHARM GMBH DE 10963 Berlin Company Details and Competitors
Table Helm AG DE 20097 Hamburg Company Details and Competitors
Table HEMMO PHARMACEUTICALS PVT. LTD. IN 400 613 Mumbai Company Details and Competitors
Table Ind-Swift Laboratories Limited IN 160 101 Chandigarh Company Details and Competitors
Table Invitrogen Corporation US 92008 Carlsbad Company Details and Competitors
Table IPCA Laboratories Limited IN 400 067 Mumbai Company Details and Competitors
Table JUBILANT GENERICS LIMITED IN 571 302 Nanjangud Company Details and Competitors
Table KRKA d.d. SI 8501 Novo Mesto Company Details and Competitors
Table Laboratori Derivati Organici S.p.A. IT 20122 Milano Company Details and Competitors
Table LEO PHARMA A/S DK 2750 Ballerup Company Details and Competitors
Table LIFE TECHNOLOGIES CORPORATION US 92008 Carlsbad Company Details and Competitors
Table Lonza Braine S.A. BE 1420 Braine-L'Alleud Company Details and Competitors
Table MIDAS PHARMA GMBH DE 55218 Ingelheim am Rhein Company Details and Competitors
Table MP BIOMEDICALS NEW ZEALAND LIMITED NZ 0610 Auckland Company Details and Competitors
Table MSN LABORATORIES PRIVATE LIMITED IN 502 329 Rudraram Village Company Details and Competitors
Table MYLAN LABORATORIES LIMITED IN 502 325 Hyderabad Company Details and Competitors
Table Global Blood system drugs Sales () by Regions (2012-2017)
Table Global Blood system drugs Sales Share by Regions (2012-2017)
Figure Global Blood system drugs Sales Market Share by Regions in 2016
Figure Global Blood system drugs Sales Market Share by Regions in 2017
Table Global Blood system drugs Revenue (Million USD) by Regions (2012-2017)
Table Global Blood system drugs Revenue Market Share by Regions (2012-2017)
Figure Global Blood system drugs Revenue Market Share by Regions in 2016
Figure Global Blood system drugs Revenue Market Share by Regions in 2017
Table Global Blood system drugs Price () by Regions (2012-2017)
Table North America Blood system drugs Sales () by Regions (2012-2017)
Table North America Blood system drugs Revenue (Million USD) by Regions (2012-2017)
Figure North America Blood system drugs Sales () and Growth Rate (2012-2017)
Table Latin America Blood system drugs Sales () by Regions (2012-2017)
Table Latin America Blood system drugs Revenue (Million USD) by Regions (2012-2017)
Figure Latin America Blood system drugs Sales () and Growth Rate (2012-2017)
Table Europe Blood system drugs Sales () by Regions (2012-2017)
Table Europe Blood system drugs Revenue (Million USD) by Regions (2012-2017)
Figure Europe Blood system drugs Sales () and Growth Rate (2012-2017)
Table Asia & Pacific Blood system drugs Sales () by Regions (2012-2017)
Table Asia & Pacific Blood system drugs Revenue (Million USD) by Regions (2012-2017)
Figure Asia & Pacific Blood system drugs Sales () and Growth Rate (2012-2017)
Table Africa & Middle East Blood system drugs Sales () by Regions (2012-2017)
Table Africa & Middle East Blood system drugs Revenue (Million USD) by Regions (2012-2017)
Figure Africa & Middle East Blood system drugs Sales () and Growth Rate (2012-2017)
Table Global Blood system drugs Sales Volume () by Key Players 2012-2017
Table Global Blood system drugs Sales Volume Market Share by Key Players 2012-2017
Figure Global Blood system drugs Sales Volume Market Share by Key Players 2016
Figure Global Blood system drugs Sales Volume Market Share by Key Players 2017
Table Global Blood system drugs Revenue (Million USD) by Key Players 2012-2017
Table Global Blood system drugs Revenue Market Share by Key Players 2012-2017
Figure Global Blood system drugs Revenue Market Share by Key Players 2016
Figure Global Blood system drugs Revenue Market Share by Key Players 2017
Table Global Top Players Key Product Model and Market Performance
Table Global Top Players Key Target Consumers and Market Performance
Table Europe Blood system drugs Sales Volume () by Key Players 2012-2017
Table Europe Blood system drugs Sales Volume Market Share by Key Players 2012-2017
Figure Europe Blood system drugs Sales Volume Market Share by Key Players 2016
Figure Europe Blood system drugs Sales Volume Market Share by Key Players 2017
Table Europe Blood system drugs Revenue (Million USD) by Key Players 2012-2017
Table Europe Blood system drugs Revenue Market Share by Key Players 2012-2017
Figure Europe Blood system drugs Revenue Market Share by Key Players 2016
Figure Europe Blood system drugs Revenue Market Share by Key Players 2017
Table Europe Top Players Key Product Model and Market Performance
Table Europe Top Players Key Target Consumers and Market Performance
Table Global Blood system drugs Sales () by Consumer (2012-2017)
Figure Global Blood system drugs Sales Market Share by Consumer (2012-2017)
Figure Global Blood system drugs Sales Market Share by Consumer in 2016
Figure Global department of hematology Blood system drugs Sales () and Growth Rate (2012-2017)
Figure Global Internal Medicine Blood system drugs Sales () and Growth Rate (2012-2017)
Figure Global department of surgery Blood system drugs Sales () and Growth Rate (2012-2017)
Figure Global Pharmacy Blood system drugs Sales () and Growth Rate (2012-2017)
Figure Global Hospital Blood system drugs Sales () and Growth Rate (2012-2017)
Table Europe Blood system drugs Sales () by Consumer (2012-2017)
Figure Europe Blood system drugs Sales Market Share by Consumer (2012-2017)
Figure Europe Blood system drugs Sales Market Share by Consumer in 2016
Figure Europe department of hematology Blood system drugs Sales () and Growth Rate (2012-2017)
Figure Europe Internal Medicine Blood system drugs Sales () and Growth Rate (2012-2017)
Figure Europe department of surgery Blood system drugs Sales () and Growth Rate (2012-2017)
Figure Europe Pharmacy Blood system drugs Sales () and Growth Rate (2012-2017)
Figure Europe Hospital Blood system drugs Sales () and Growth Rate (2012-2017)
Figure Global Blood system drugs Sales () and Growth Rate (%) Forecast (2017-2022)
Figure Global Blood system drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Blood system drugs Price () Trend Forecast (2017-2022)
Table Global Blood system drugs Sales () Forecast by Regions (2017-2022)
Table Global Blood system drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Blood system drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Blood system drugs Sales Volume Share Forecast by Regions in 2022
Table Global Blood system drugs Sales () Forecast by Application (2017-2022)
Figure Global Blood system drugs Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Blood system drugs Sales Volume Market Share Forecast by Application in 2022
Table Global Blood system drugs Sales () Forecast by Antianemic Agents (2017-2022)
Figure Global Blood system drugs Sales () Forecast by Antianemic Agents (2017-2022)
Figure Global Blood system drugs Sales Volume Market Share Forecast by Antianemic Agents in 2022
Table Global Blood system drugs Sales () Forecast by Antiplatelet drug (2017-2022)
Figure Global Blood system drugs Sales () Forecast by Antiplatelet drug (2017-2022)
Figure Global Blood system drugs Sales Volume Market Share Forecast by Antiplatelet drug in 2022
Table Global Blood system drugs Sales () Forecast by Coagulant Drugs (2017-2022)
Figure Global Blood system drugs Sales () Forecast by Coagulant Drugs (2017-2022)
Figure Global Blood system drugs Sales Volume Market Share Forecast by Coagulant Drugs in 2022
Table Global Blood system drugs Sales () Forecast by Anticoagulant and thrombolytic (2017-2022)
Figure Global Blood system drugs Sales () Forecast by Anticoagulant and thrombolytic (2017-2022)
Table Global Blood system drugs Sales Volume (), Revenue (Million USD) and Price () (2012-2017)
Figure Global Blood system drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Global Blood system drugs Sales Volume () and Growth Rate (2012-2017)
Table Global Blood system drugs Sales () by Antianemic Agents (2012-2017)
Table Global Blood system drugs Sales Market Share by Antianemic Agents (2012-2017)
Figure Global Blood system drugs Sales Market Share by Antianemic Agents in 2016
Table Global Blood system drugs Revenue (Million USD) by Antianemic Agents (2012-2017)
Table Global Blood system drugs Revenue Market Share by Antianemic Agents (2012-2017)
Figure Global Blood system drugs Revenue Market Share by Antianemic Agents in 2016
Table Global Blood system drugs Price () by Antianemic Agents (2012-2017)
Table Top Players of Ferrous sulfate Blood system drugs Products List
Figure Global Ferrous sulfate Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Ferrous succinate Blood system drugs Products List
Figure Global Ferrous succinate Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of RHUEPO Blood system drugs Products List
Figure Global RHUEPO Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Iron-dextrin Blood system drugs Products List
Figure Global Iron-dextrin Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Vitamin B12 Blood system drugs Products List
Figure Global Vitamin B12 Blood system drugs Sales () and Growth Rate (2012-2017)
Table Global Blood system drugs Sales () by Antiplatelet drug (2012-2017)
Table Global Blood system drugs Sales Market Share by Antiplatelet drug (2012-2017)
Figure Global Blood system drugs Sales Market Share by Antiplatelet drug in 2016
Table Global Blood system drugs Revenue (Million USD) by Antiplatelet drug (2012-2017)
Table Global Blood system drugs Revenue Market Share by Antiplatelet drug (2012-2017)
Figure Global Blood system drugs Revenue Market Share by Antiplatelet drug in 2016
Table Global Blood system drugs Price () by Antiplatelet drug (2012-2017)
Table Top Players of Aspirin Blood system drugs Products List
Figure Global Aspirin Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Dipyridamole Blood system drugs Products List
Figure Global Dipyridamole Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Clopidogrel Blood system drugs Products List
Figure Global Clopidogrel Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Prasugrel Blood system drugs Products List
Figure Global Prasugrel Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Ticagrelor Blood system drugs Products List
Figure Global Ticagrelor Blood system drugs Sales () and Growth Rate (2012-2017)
Table Global Blood system drugs Sales () by Coagulant Drugs (2012-2017)
Table Global Blood system drugs Sales Market Share by Coagulant Drugs (2012-2017)
Figure Global Blood system drugs Sales Market Share by Coagulant Drugs in 2016
Table Global Blood system drugs Revenue (Million USD) by Coagulant Drugs (2012-2017)
Table Global Blood system drugs Revenue Market Share by Coagulant Drugs (2012-2017)
Figure Global Blood system drugs Revenue Market Share by Coagulant Drugs in 2016
Table Global Blood system drugs Price () by Coagulant Drugs (2012-2017)
Table Top Players of Thrombin Blood system drugs Products List
Figure Global Thrombin Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Etamsylate Blood system drugs Products List
Figure Global Etamsylate Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Menadione Sodium Bisulfite Blood system drugs Products List
Figure Global Menadione Sodium Bisulfite Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Vitamin K1 Blood system drugs Products List
Figure Global Vitamin K1 Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Aminomethylbenzoic Acid Blood system drugs Products List
Figure Global Aminomethylbenzoic Acid Blood system drugs Sales () and Growth Rate (2012-2017)
Table Global Blood system drugs Sales () by Anticoagulant and thrombolytic (2012-2017)
Table Global Blood system drugs Sales Market Share by Anticoagulant and thrombolytic (2012-2017)
Figure Global Blood system drugs Sales Market Share by Anticoagulant and thrombolytic in 2016
Table Global Blood system drugs Revenue (Million USD) by Anticoagulant and thrombolytic (2012-2017)
Table Global Blood system drugs Revenue Market Share by Anticoagulant and thrombolytic (2012-2017)
Figure Global Blood system drugs Revenue Market Share by Anticoagulant and thrombolytic in 2016
Table Global Blood system drugs Price () by Anticoagulant and thrombolytic (2012-2017)
Table Top Players of heparin Blood system drugs Products List
Figure Global heparin Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of urokinase Blood system drugs Products List
Figure Global urokinase Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Warfarin Blood system drugs Products List
Figure Global Warfarin Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Bishydroxycoumarin Blood system drugs Products List
Figure Global Bishydroxycoumarin Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Streptokinase Blood system drugs Products List
Figure Global Streptokinase Blood system drugs Sales () and Growth Rate (2012-2017)
Table Global Blood system drugs Sales () by blood volume expander (2012-2017)
Table Global Blood system drugs Sales Market Share by blood volume expander (2012-2017)
Figure Global Blood system drugs Sales Market Share by blood volume expander in 2016
Table Global Blood system drugs Revenue (Million USD) by blood volume expander (2012-2017)
Table Global Blood system drugs Revenue Market Share by blood volume expander (2012-2017)
Figure Global Blood system drugs Revenue Market Share by blood volume expander in 2016
Table Global Blood system drugs Price () by blood volume expander (2012-2017)
Table Top Players of Hydroxyethyl starch 40 Blood system drugs Products List
Figure Global Hydroxyethyl starch 40 Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Dextran Blood system drugs Products List
Figure Global Dextran Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Polyglucose Blood system drugs Products List
Figure Global Polyglucose Blood system drugs Sales () and Growth Rate (2012-2017)
Table Europe Blood system drugs Sales Volume (), Revenue (Million USD) and Price () (2012-2017)
Figure Europe Blood system drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Blood system drugs Sales Volume () and Growth Rate (2012-2017)
Table Europe Blood system drugs Sales () by Antianemic Agents (2012-2017)
Table Europe Blood system drugs Sales Market Share by Antianemic Agents (2012-2017)
Figure Europe Blood system drugs Sales Market Share by Antianemic Agents in 2016
Table Europe Blood system drugs Revenue (Million USD) by Antianemic Agents (2012-2017)
Table Europe Blood system drugs Revenue Market Share by Antianemic Agents (2012-2017)
Figure Europe Blood system drugs Revenue Market Share by Antianemic Agents in 2016
Table Europe Blood system drugs Price () by Antianemic Agents (2012-2017)
Table Top Players of Ferrous sulfate Blood system drugs Products List
Figure Europe Ferrous sulfate Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Ferrous succinate Blood system drugs Products List
Figure Europe Ferrous succinate Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of RHUEPO Blood system drugs Products List
Figure Europe RHUEPO Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Iron-dextrin Blood system drugs Products List
Figure Europe Iron-dextrin Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Vitamin B12 Blood system drugs Products List
Figure Europe Vitamin B12 Blood system drugs Sales () and Growth Rate (2012-2017)
Table Europe Blood system drugs Sales () by Antiplatelet drug (2012-2017)
Table Europe Blood system drugs Sales Market Share by Antiplatelet drug (2012-2017)
Figure Europe Blood system drugs Sales Market Share by Antiplatelet drug in 2016
Table Europe Blood system drugs Revenue (Million USD) by Antiplatelet drug (2012-2017)
Table Europe Blood system drugs Revenue Market Share by Antiplatelet drug (2012-2017)
Figure Europe Blood system drugs Revenue Market Share by Antiplatelet drug in 2016
Table Europe Blood system drugs Price () by Antiplatelet drug (2012-2017)
Table Top Players of Aspirin Blood system drugs Products List
Figure Europe Aspirin Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Dipyridamole Blood system drugs Products List
Figure Europe Dipyridamole Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Clopidogrel Blood system drugs Products List
Figure Europe Clopidogrel Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Prasugrel Blood system drugs Products List
Figure Europe Prasugrel Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Ticagrelor Blood system drugs Products List
Figure Europe Ticagrelor Blood system drugs Sales () and Growth Rate (2012-2017)
Table Europe Blood system drugs Sales () by Coagulant Drugs (2012-2017)
Table Europe Blood system drugs Sales Market Share by Coagulant Drugs (2012-2017)
Figure Europe Blood system drugs Sales Market Share by Coagulant Drugs in 2016
Table Europe Blood system drugs Revenue (Million USD) by Coagulant Drugs (2012-2017)
Table Europe Blood system drugs Revenue Market Share by Coagulant Drugs (2012-2017)
Figure Europe Blood system drugs Revenue Market Share by Coagulant Drugs in 2016
Table Europe Blood system drugs Price () by Coagulant Drugs (2012-2017)
Table Top Players of Thrombin Blood system drugs Products List
Figure Europe Thrombin Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Etamsylate Blood system drugs Products List
Figure Europe Etamsylate Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Menadione Sodium Bisulfite Blood system drugs Products List
Figure Europe Menadione Sodium Bisulfite Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Vitamin K1 Blood system drugs Products List
Figure Europe Vitamin K1 Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Aminomethylbenzoic Acid Blood system drugs Products List
Figure Europe Aminomethylbenzoic Acid Blood system drugs Sales () and Growth Rate (2012-2017)
Table Europe Blood system drugs Sales () by Anticoagulant and thrombolytic (2012-2017)
Table Europe Blood system drugs Sales Market Share by Anticoagulant and thrombolytic (2012-2017)
Figure Europe Blood system drugs Sales Market Share by Anticoagulant and thrombolytic in 2016
Table Europe Blood system drugs Revenue (Million USD) by Anticoagulant and thrombolytic (2012-2017)
Table Europe Blood system drugs Revenue Market Share by Anticoagulant and thrombolytic (2012-2017)
Figure Europe Blood system drugs Revenue Market Share by Anticoagulant and thrombolytic in 2016
Table Europe Blood system drugs Price () by Anticoagulant and thrombolytic (2012-2017)
Table Top Players of heparin Blood system drugs Products List
Figure Europe heparin Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of urokinase Blood system drugs Products List
Figure Europe urokinase Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Warfarin Blood system drugs Products List
Figure Europe Warfarin Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Bishydroxycoumarin Blood system drugs Products List
Figure Europe Bishydroxycoumarin Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Streptokinase Blood system drugs Products List
Figure Europe Streptokinase Blood system drugs Sales () and Growth Rate (2012-2017)
Table Europe Blood system drugs Sales () by blood volume expander (2012-2017)
Table Europe Blood system drugs Sales Market Share by blood volume expander (2012-2017)
Figure Europe Blood system drugs Sales Market Share by blood volume expander in 2016
Table Europe Blood system drugs Revenue (Million USD) by blood volume expander (2012-2017)
Table Europe Blood system drugs Revenue Market Share by blood volume expander (2012-2017)
Figure Europe Blood system drugs Revenue Market Share by blood volume expander in 2016
Table Europe Blood system drugs Price () by blood volume expander (2012-2017)
Table Top Players of Hydroxyethyl starch 40 Blood system drugs Products List
Figure Europe Hydroxyethyl starch 40 Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Dextran Blood system drugs Products List
Figure Europe Dextran Blood system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Polyglucose Blood system drugs Products List
Figure Europe Polyglucose Blood system drugs Sales () and Growth Rate (2012-2017)
Table ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Company Details and Competitors
Table ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Key Blood system drugs Models and Performance
Table ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Blood system drugs Business SWOT Analysis and Forecast
Table ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Blood system drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Blood system drugs Sales Market Share (%) in Global (2012-2017)
Figure ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Blood system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Blood system drugs Revenue Market Share (%) in Global (2012-2017)
Table Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free Company Details and Competitors
Table Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free Key Blood system drugs Models and Performance
Table Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free Blood system drugs Business SWOT Analysis and Forecast
Table Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free Blood system drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free Blood system drugs Sales Market Share (%) in Global (2012-2017)
Figure Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free Blood system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Aprotinin concentrated solution Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free Blood system drugs Revenue Market Share (%) in Global (2012-2017)
Table ASPEN OSS B.V. NL 5349 AB Oss Company Details and Competitors
Table ASPEN OSS B.V. NL 5349 AB Oss Key Blood system drugs Models and Performance
Table ASPEN OSS B.V. NL 5349 AB Oss Blood system drugs Business SWOT Analysis and Forecast
Table ASPEN OSS B.V. NL 5349 AB Oss Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure ASPEN OSS B.V. NL 5349 AB Oss Blood system drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure ASPEN OSS B.V. NL 5349 AB Oss Blood system drugs Sales Market Share (%) in Global (2012-2017)
Figure ASPEN OSS B.V. NL 5349 AB Oss Blood system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure ASPEN OSS B.V. NL 5349 AB Oss Blood system drugs Revenue Market Share (%) in Global (2012-2017)
Table BACHEM AMERICAS, INC. US 90505 Torrance Company Details and Competitors
Table BACHEM AMERICAS, INC. US 90505 Torrance Key Blood system drugs Models and Performance
Table BACHEM AMERICAS, INC. US 90505 Torrance Blood system drugs Business SWOT Analysis and Forecast
Table BACHEM AMERICAS, INC. US 90505 Torrance Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure BACHEM AMERICAS, INC. US 90505 Torrance Blood system drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure BACHEM AMERICAS, INC. US 90505 Torrance Blood system drugs Sales Market Share (%) in Global (2012-2017)
Figure BACHEM AMERICAS, INC. US 90505 Torrance Blood system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure BACHEM AMERICAS, INC. US 90505 Torrance Blood system drugs Revenue Market Share (%) in Global (2012-2017)
Table BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona Company Details and Competitors
Table BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona Key Blood system drugs Models and Performance
Table BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona Blood system drugs Business SWOT Analysis and Forecast
Table BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona Blood system drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona Blood system drugs Sales Market Share (%) in Global (2012-2017)
Figure BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona Blood system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure BCN PEPTIDES S.A. ES 08777 St Quinti De Mediona Blood system drugs Revenue Market Share (%) in Global (2012-2017)
Table Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar Company Details and Competitors
Table Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar Key Blood system drugs Models and Performance
Table Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar Blood system drugs Business SWOT Analysis and Forecast
Table Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar Blood system drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar Blood system drugs Sales Market Share (%) in Global (2012-2017)
Figure Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar Blood system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Boehringer Ingelheim Espa?a S.A. ES 08380 Malgrat De Mar Blood system drugs Revenue Market Share (%) in Global (2012-2017)
Table CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village Company Details and Competitors
Table CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village Key Blood system drugs Models and Performance
Table CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village Blood system drugs Business SWOT Analysis and Forecast
Table CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village Blood system drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village Blood system drugs Sales Market Share (%) in Global (2012-2017)
Figure CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village Blood system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure CADILA HEALTHCARE LIMITED IN 391 440 Dabhasa Village Blood system drugs Revenue Market Share (%) in Global (2012-2017)
Table CHEMOSWED AB SE 212 15 Malm Company Details and Competitors
Table CHEMOSWED AB SE 212 15 Malm Key Blood system drugs Models and Performance
Table CHEMOSWED AB SE 212 15 Malm Blood system drugs Business SWOT Analysis and Forecast
Table CHEMOSWED AB SE 212 15 Malm Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure CHEMOSWED AB SE 212 15 Malm Blood system drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure CHEMOSWED AB SE 212 15 Malm Blood system drugs Sales Market Share (%) in Global (2012-2017)
Figure CHEMOSWED AB SE 212 15 Malm Blood system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure CHEMOSWED AB SE 212 15 Malm Blood system drugs Revenue Market Share (%) in Global (2012-2017)
Table Cilag AG CH 8205 Schaffhausen Company Details and Competitors
Table Cilag AG CH 8205 Schaffhausen Key Blood system drugs Models and Performance
Table Cilag AG CH 8205 Schaffhausen Blood system drugs Business SWOT Analysis and Forecast
Table Cilag AG CH 8205 Schaffhausen Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure Cilag AG CH 8205 Schaffhausen Blood system drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure Cilag AG CH 8205 Schaffhausen Blood system drugs Sales Market Share (%) in Global (2012-2017)
Figure Cilag AG CH 8205 Schaffhausen Blood system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Cilag AG CH 8205 Schaffhausen Blood system drugs Revenue Market Share (%) in Global (2012-2017)
Table DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch Company Details and Competitors
Table DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch Key Blood system drugs Models and Performance
Table DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch Blood system drugs Business SWOT Analysis and Forecast
Table DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch Blood system drugs Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch Blood system drugs Sales Market Share (%) in Global (2012-2017)
Figure DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch Blood system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM CH 4147 Aesch Blood system drugs Revenue Market Share (%) in Global (2012-2017)
Table Erregierre S.p.A. IT 24060 San Paolo D'Argon Company Details and Competitors
Table ESTEVE QUIMICA S.A. ES 08024 Barcelona Company Details and Competitors
Table FSP GALENA PL 50-984 Wroclaw Company Details and Competitors
Table HEC PHARM GMBH DE 10963 Berlin Company Details and Competitors
Table Helm AG DE 20097 Hamburg Company Details and Competitors
Table HEMMO PHARMACEUTICALS PVT. LTD. IN 400 613 Mumbai Company Details and Competitors
Table Ind-Swift Laboratories Limited IN 160 101 Chandigarh Company Details and Competitors
Table Invitrogen Corporation US 92008 Carlsbad Company Details and Competitors
Table IPCA Laboratories Limited IN 400 067 Mumbai Company Details and Competitors
Table JUBILANT GENERICS LIMITED IN 571 302 Nanjangud Company Details and Competitors
Table KRKA d.d. SI 8501 Novo Mesto Company Details and Competitors
Table Laboratori Derivati Organici S.p.A. IT 20122 Milano Company Details and Competitors
Table LEO PHARMA A/S DK 2750 Ballerup Company Details and Competitors
Table LIFE TECHNOLOGIES CORPORATION US 92008 Carlsbad Company Details and Competitors
Table Lonza Braine S.A. BE 1420 Braine-L'Alleud Company Details and Competitors
Table MIDAS PHARMA GMBH DE 55218 Ingelheim am Rhein Company Details and Competitors
Table MP BIOMEDICALS NEW ZEALAND LIMITED NZ 0610 Auckland Company Details and Competitors
Table MSN LABORATORIES PRIVATE LIMITED IN 502 329 Rudraram Village Company Details and Competitors
Table MYLAN LABORATORIES LIMITED IN 502 325 Hyderabad Company Details and Competitors
Table Global Blood system drugs Sales () by Regions (2012-2017)
Table Global Blood system drugs Sales Share by Regions (2012-2017)
Figure Global Blood system drugs Sales Market Share by Regions in 2016
Figure Global Blood system drugs Sales Market Share by Regions in 2017
Table Global Blood system drugs Revenue (Million USD) by Regions (2012-2017)
Table Global Blood system drugs Revenue Market Share by Regions (2012-2017)
Figure Global Blood system drugs Revenue Market Share by Regions in 2016
Figure Global Blood system drugs Revenue Market Share by Regions in 2017
Table Global Blood system drugs Price () by Regions (2012-2017)
Table North America Blood system drugs Sales () by Regions (2012-2017)
Table North America Blood system drugs Revenue (Million USD) by Regions (2012-2017)
Figure North America Blood system drugs Sales () and Growth Rate (2012-2017)
Table Latin America Blood system drugs Sales () by Regions (2012-2017)
Table Latin America Blood system drugs Revenue (Million USD) by Regions (2012-2017)
Figure Latin America Blood system drugs Sales () and Growth Rate (2012-2017)
Table Europe Blood system drugs Sales () by Regions (2012-2017)
Table Europe Blood system drugs Revenue (Million USD) by Regions (2012-2017)
Figure Europe Blood system drugs Sales () and Growth Rate (2012-2017)
Table Asia & Pacific Blood system drugs Sales () by Regions (2012-2017)
Table Asia & Pacific Blood system drugs Revenue (Million USD) by Regions (2012-2017)
Figure Asia & Pacific Blood system drugs Sales () and Growth Rate (2012-2017)
Table Africa & Middle East Blood system drugs Sales () by Regions (2012-2017)
Table Africa & Middle East Blood system drugs Revenue (Million USD) by Regions (2012-2017)
Figure Africa & Middle East Blood system drugs Sales () and Growth Rate (2012-2017)
Table Global Blood system drugs Sales Volume () by Key Players 2012-2017
Table Global Blood system drugs Sales Volume Market Share by Key Players 2012-2017
Figure Global Blood system drugs Sales Volume Market Share by Key Players 2016
Figure Global Blood system drugs Sales Volume Market Share by Key Players 2017
Table Global Blood system drugs Revenue (Million USD) by Key Players 2012-2017
Table Global Blood system drugs Revenue Market Share by Key Players 2012-2017
Figure Global Blood system drugs Revenue Market Share by Key Players 2016
Figure Global Blood system drugs Revenue Market Share by Key Players 2017
Table Global Top Players Key Product Model and Market Performance
Table Global Top Players Key Target Consumers and Market Performance
Table Europe Blood system drugs Sales Volume () by Key Players 2012-2017
Table Europe Blood system drugs Sales Volume Market Share by Key Players 2012-2017
Figure Europe Blood system drugs Sales Volume Market Share by Key Players 2016
Figure Europe Blood system drugs Sales Volume Market Share by Key Players 2017
Table Europe Blood system drugs Revenue (Million USD) by Key Players 2012-2017
Table Europe Blood system drugs Revenue Market Share by Key Players 2012-2017
Figure Europe Blood system drugs Revenue Market Share by Key Players 2016
Figure Europe Blood system drugs Revenue Market Share by Key Players 2017
Table Europe Top Players Key Product Model and Market Performance
Table Europe Top Players Key Target Consumers and Market Performance
Table Global Blood system drugs Sales () by Consumer (2012-2017)
Figure Global Blood system drugs Sales Market Share by Consumer (2012-2017)
Figure Global Blood system drugs Sales Market Share by Consumer in 2016
Figure Global department of hematology Blood system drugs Sales () and Growth Rate (2012-2017)
Figure Global Internal Medicine Blood system drugs Sales () and Growth Rate (2012-2017)
Figure Global department of surgery Blood system drugs Sales () and Growth Rate (2012-2017)
Figure Global Pharmacy Blood system drugs Sales () and Growth Rate (2012-2017)
Figure Global Hospital Blood system drugs Sales () and Growth Rate (2012-2017)
Table Europe Blood system drugs Sales () by Consumer (2012-2017)
Figure Europe Blood system drugs Sales Market Share by Consumer (2012-2017)
Figure Europe Blood system drugs Sales Market Share by Consumer in 2016
Figure Europe department of hematology Blood system drugs Sales () and Growth Rate (2012-2017)
Figure Europe Internal Medicine Blood system drugs Sales () and Growth Rate (2012-2017)
Figure Europe department of surgery Blood system drugs Sales () and Growth Rate (2012-2017)
Figure Europe Pharmacy Blood system drugs Sales () and Growth Rate (2012-2017)
Figure Europe Hospital Blood system drugs Sales () and Growth Rate (2012-2017)
Figure Global Blood system drugs Sales () and Growth Rate (%) Forecast (2017-2022)
Figure Global Blood system drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Blood system drugs Price () Trend Forecast (2017-2022)
Table Global Blood system drugs Sales () Forecast by Regions (2017-2022)
Table Global Blood system drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Blood system drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Blood system drugs Sales Volume Share Forecast by Regions in 2022
Table Global Blood system drugs Sales () Forecast by Application (2017-2022)
Figure Global Blood system drugs Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Blood system drugs Sales Volume Market Share Forecast by Application in 2022
Table Global Blood system drugs Sales () Forecast by Antianemic Agents (2017-2022)
Figure Global Blood system drugs Sales () Forecast by Antianemic Agents (2017-2022)
Figure Global Blood system drugs Sales Volume Market Share Forecast by Antianemic Agents in 2022
Table Global Blood system drugs Sales () Forecast by Antiplatelet drug (2017-2022)
Figure Global Blood system drugs Sales () Forecast by Antiplatelet drug (2017-2022)
Figure Global Blood system drugs Sales Volume Market Share Forecast by Antiplatelet drug in 2022
Table Global Blood system drugs Sales () Forecast by Coagulant Drugs (2017-2022)
Figure Global Blood system drugs Sales () Forecast by Coagulant Drugs (2017-2022)
Figure Global Blood system drugs Sales Volume Market Share Forecast by Coagulant Drugs in 2022
Table Global Blood system drugs Sales () Forecast by Anticoagulant and thrombolytic (2017-2022)
Figure Global Blood system drugs Sales () Forecast by Anticoagulant and thrombolytic (2017-2022)
